T1	Pharmacological_substance 53 76	all-trans retinoic acid
N1000 	Reference T1 MeSH:D014212	all-trans retinoic acid
T2	Pharmacological_substance 119 142	All-trans-retinoic acid
N1001 	Reference T2 MeSH:D014212	All-trans-retinoic acid
T3	Pharmacological_substance 144 148	ATRA
N1002 	Reference T3 MeSH:D014212	ATRA
T4	Disorder 199 227	acute promyelocytic leukemia
N1 	Reference T4 UMLS:C0023487	acute promyelocytic leukemia
T6	Pharmacological_substance 342 346	ATRA
N1003 	Reference T6 MeSH:D014212	ATRA
T7	Pharmacological_substance 400 409	retinoids
N1004 	Reference T7 MeSH:D012176	retinoids
T8	Pharmacological_substance 463 467	ATRA
N1005 	Reference T8 MeSH:D014212	ATRA
T9	Pharmacological_substance 589 593	ATRA
N1006 	Reference T9 MeSH:D014212	ATRA
T11	Disorder 229 232	APL
N2 	Reference T11 UMLS:C0023487	APL
T12	Subject 431 451	pregnancy in a woman
T14	Disorder 647 667	congenital anomalies
N3 	Reference T14 UMLS:C0000768	congenital anomalies
T15	Disorder 627 643	adverse outcomes
T18	Manner_cue 616 626	no serious
T19	Disorder 523 544	without any anomalies
N4 	Reference T19 UMLS:C0003113	without any anomalies
T20	Subject 677 696	only very few cases
T22	Disorder 294 297	APL
N5 	Reference T22 UMLS:C0023487	APL
T24	Subject 21 39	pregnancy in women
T27	Speculation_cue 356 366	questioned
T28	Subject 500 504	baby
